Asthma

Disease State Hub

FDA Alerts

asthma

FDA Approves 2 New Options for Asthma Treatment

01/30/2017

The FDA has approved AirDuo RespiClick and ArmonAir RespiClick for the treatment of adolescent and adult patients with asthma.

01/30/2017

Asthma

FDA Issues First Federal Regulations on E-Cigarettes

05/06/2016

The FDA finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco, and pipe tobacco, among others.

05/06/2016

COPD

FDA Approves New Indication for COPD Drug

09/18/2015

The FDA has approved a drug already indicated for COPD treatment for the long-term, once-daily maintenance of asthma in individuals 12 years old and older.

09/18/2015

Asthma Snapshot

Reviewed by Albert Rizzo, MD

For allergic asthma content, visit the Disease State Hub

Asthma is a chronic inflammatory disease that can cause airflow obstruction. The airways can become inflamed and narrowed, making it difficult for air to flow when breathing out. About 1 in 13 people in the US has asthma, according to the CDC.

For more allergy content, visit the Resource Center

Primary Care, Pediatricians, Pulmonologists, Allergists, Respiratory Specialists, Internists

For more on the management of asthma, visit the Multidisciplinary Roundtable

Asthma attacks happen when the airways swell and narrow, making it harder to breathe. Attacks can come on fast or gradually and may be life-threatening. People with severe asthma tend to get asthma attacks more often.

For more expert perspective, visit the clinical insights page

Spirometry
FeNO Test
Trigger Tests
Allergy Tests

For polls and quizzes, visit the interactive features page

People with asthma in the United States, broken down by sex

For more pediatrics content, visit the Resource Center

Roughly the number of children under the age of 18 with asthma in the United States

June 2026

Current Issue

June 2026